CTOs on the Move


 
Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.elucid.com
  • 2 Park Plaza Suite 700
    Boston, MA USA 02116
  • Phone: 617.329.9487

Executives

Name Title Contact Details
Andrew Miller
Chief Technology Officer Profile

Funding

Elucid raised $27M on 06/22/2022

Similar Companies

Pointshare Corporation

Pointshare Corporation is a Issaquah, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Prisim Medical Products (was Freeway Healthcare)

Prisim Medical Products (was Freeway Healthcare) is a Elkin, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Swiss-American Products dba as elta Skin and Wounc Care

Swiss-American Products dba as elta Skin and Wounc Care is a Carrollton, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GT Medical Technologies

Driven to raise the standard of care and improve the lives of patients with brain tumors, a team of brain tumor specialists formed GT Medical Technologies. FDA-cleared GammaTile Therapy is a Surgically Targeted Radiation Therapy (STaRT) for patients undergoing brain tumor removal surgery of newly diagnosed malignant and recurrent brain tumors. This "one-and-done" treatment eliminates the need for one to six weeks of daily external beam radiation therapy, allowing patients to go about their daily lives without the burden of additional trips to the hospital or clinic for ongoing treatment. Since its full market release in the United States in March 2020, GammaTile has been offered in more than 95 hospitals, with more centers being added each month.

Oncura

Oncura is a Arlington Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.